These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2252310)

  • 1. 5-HT3 receptors.
    Tyers MB
    Ann N Y Acad Sci; 1990; 600():194-202; discussion 202-5. PubMed ID: 2252310
    [No Abstract]   [Full Text] [Related]  

  • 2. The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties.
    Hamon M; Gozlan H; el Mestikawy S; Emerit MB; Bolaños F; Schechter L
    Ann N Y Acad Sci; 1990; 600():114-29; discussion 129-31. PubMed ID: 2252305
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonin 5-HT3 and 5-HT4 receptor antagonists.
    Gaster LM; King FD
    Med Res Rev; 1997 Mar; 17(2):163-214. PubMed ID: 9057164
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
    Tyers MB
    Therapie; 1991; 46(6):431-5. PubMed ID: 1840227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT3 receptors and central effects of ethanol.
    Kostowski W
    Pol J Pharmacol; 1996; 48(3):243-54. PubMed ID: 9112659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties and functions of central 5-HT3 receptors.
    Costall B; Naylor RJ
    Therapie; 1991; 46(6):437-44. PubMed ID: 1840228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serotonin receptors (results of the pharmacological study)].
    Valeeva LA; Sergeev PV; Shimanovskiĭ NL
    Eksp Klin Farmakol; 1997; 60(6):57-61. PubMed ID: 9460603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT6 receptor ligands and their antipsychotic potential.
    Arnt J; Olsen CK
    Int Rev Neurobiol; 2011; 96():141-61. PubMed ID: 21329787
    [No Abstract]   [Full Text] [Related]  

  • 11. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
    Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
    Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats.
    Chen J; Paredes W; Van Praag HM; Lowinson JH; Gardner EL
    Synapse; 1992 Mar; 10(3):264-6. PubMed ID: 1557698
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study.
    Ashby CR; Minabe Y; Edwards E; Wang RY
    Brain Res; 1991 Jun; 550(2):181-91. PubMed ID: 1679370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous 5-hydroxytryptamine modulates the release of tachykinins and calcitonin gene-related peptide from the rat spinal cord via 5-HT3 receptors.
    Saria A; Javorsky F; Humpel C; Gamse R
    Ann N Y Acad Sci; 1991; 632():464-5. PubMed ID: 1719904
    [No Abstract]   [Full Text] [Related]  

  • 15. [New discoveries on antidepressive treatment: serotonin is the key].
    Evenden J
    Lakartidningen; 1997 Sep; 94(38):3262-6. PubMed ID: 9379793
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives.
    Orjales A; Alonso-Cires L; López-Tudanca PL; Tapia I; Labeaga L; Mosquera R
    Drug Des Discov; 2000; 16(4):271-9. PubMed ID: 10807033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
    Wade PR; Mawe GM; Branchek TA; Gershon MD
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of forskolin stimulated adenylate cyclase in rat hippocampus as a screen for compounds that act through 5-HT1A receptors.
    Cornfield LJ; Nelson DL; Monroe PJ; Taylor EW; Nikam SS
    Proc West Pharmacol Soc; 1988; 31():265-7. PubMed ID: 3211913
    [No Abstract]   [Full Text] [Related]  

  • 19. [5-HT3-receptor-antagonists in therapy of rheumatic diseases].
    Müller W; Stratz T
    Z Rheumatol; 2003 Feb; 62(1):39-41. PubMed ID: 12624802
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of clozapine and other neuroleptics on binding of [3H]-Q ICS 205-930 to central 5-HT3 recognition sites.
    Watling KJ; Beer MS; Stanton JA
    Br J Pharmacol; 1989 Dec; 98 Suppl():813P. PubMed ID: 2575419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.